EPL
ALXO icon

EDBI Pte Ltd’s ALX Oncology ALXO Stock Holding History

EDBI Pte Ltd’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,613
Closed -$54K – 20
2022
Q3 		$54K Hold
5,613
– – 0.06% 23
2022
Q2 		$45K Hold
5,613
– – 0.04% 22
2022
Q1 		$95K Hold
5,613
– – 0.06% 20
2021
Q4 		$121K Buy
+5,613
New +$242K 0.07% 18

Other funds holding ALXO

VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

EDBI Pte Ltd's ALXO Position: Q4 2022 in Review

EDBI Pte Ltd sold out of ALX Oncology (ALXO) in Q4 2022, closing a stake of 5,613 shares — an estimated $54K sold.

EDBI Pte Ltd first reported a position in ALXO in Q4 2021 and held it in 4 quarters. The position peaked at $121K in Q4 2021. 86 funds tracked by Wall St. Rank hold ALXO as of Q4 2022.

  • EDBI Pte Ltd reported no remaining ALX Oncology position as of Q4 2022 after selling out during the quarter.
  • EDBI Pte Ltd sold 5,613 ALX Oncology shares in Q4 2022, an estimated $54K.
  • EDBI Pte Ltd first reported a position in ALX Oncology in Q4 2021 and held it in 4 quarters.
  • EDBI Pte Ltd's ALX Oncology position peaked at $121K in Q4 2021.
  • 86 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2022.

Based on EDBI Pte Ltd's 13F filing for Q4 2022, filed 30 Jan 2023.